Literature DB >> 20726873

Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures.

Annelies Van Dycke1, Robrecht Raedt, Ine Dauwe, Tom Sante, Tine Wyckhuys, Alfred Meurs, Kristl Vonck, Wytse Wadman, Paul Boon.   

Abstract

PURPOSE: Despite different treatment options for patients with refractory epilepsy such as epilepsy surgery and neurostimulation, many patients still have seizures and/or drug-related cerebral and systemic side effects. Local intracerebral delivery of antiepileptic compounds may represent a novel strategy with specific advantages such as the option of higher local doses and reduced side effects. In this study we evaluate the antiepileptic effect of local delivery of adenosine in the kainic acid rat model, a validated model for temporal lobe epilepsy.
METHODS: Fifteen rats, in which intraperitoneal kainic acid injection had induced spontaneous seizures, were implanted with a combination of depth electrodes and a cannula in both hippocampi. Cannulas were connected to osmotic minipumps to allow continuous hippocampal delivery. Rats were freely moving and permanently monitored by video-EEG (electroencephalography). Seizures were scored during 2 weeks of local hippocampal delivery of saline (baseline), followed by 2 weeks of local adenosine (6 mg/ml) (n = 10) or saline (n = 5) delivery (0.23 μl/h) (treatment). In 7 of 10 adenosine-treated rats, saline was also delivered during a washout period.
RESULTS: During the treatment period a mean daily seizure frequency reduction of 33% compared to the baseline rate was found in adenosine-treated rats (p < 0.01). Four rats had a seizure frequency reduction of at least 50%. Both nonconvulsive and convulsive seizures significantly decreased during the treatment period. In the saline-control group, mean daily seizure frequency increased with 35% during the treatment period.
CONCLUSIONS: This study demonstrates the antiseizure effect of continuous adenosine delivery in the hippocampi in rats with spontaneous seizures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726873     DOI: 10.1111/j.1528-1167.2010.02700.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

Review 1.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

2.  Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery.

Authors:  Annelies Van Dycke; Robrecht Raedt; Alain Verstraete; Panos Theofilas; Wytse Wadman; Kristl Vonck; Detlev Boison; Paul Boon
Journal:  Seizure       Date:  2010-06-17       Impact factor: 3.184

Review 3.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

4.  Reconstruction of the adenosine system by bone marrow-derived mesenchymal stem cell transplantation.

Authors:  Huicong Kang; Qi Hu; Xiaoyan Liu; Yinhe Liu; Feng Xu; Xiang Li; Suiqiang Zhu
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

5.  Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety.

Authors:  Joana E Coelho; Pedro Alves; Paula M Canas; Jorge S Valadas; Tatiana Shmidt; Vânia L Batalha; Diana G Ferreira; Joaquim A Ribeiro; Michael Bader; Rodrigo A Cunha; Frederico Simões do Couto; Luísa V Lopes
Journal:  Front Psychiatry       Date:  2014-06-13       Impact factor: 4.157

6.  Role of adenosine in the antiepileptic effects of deep brain stimulation.

Authors:  Maisa F Miranda; Clement Hamani; Antônio-Carlos G de Almeida; Beatriz O Amorim; Carlos E Macedo; Maria José S Fernandes; José N Nobrega; Mayra C Aarão; Ana Paula Madureira; Antônio M Rodrigues; Monica L Andersen; Sergio Tufik; Luiz E Mello; Luciene Covolan
Journal:  Front Cell Neurosci       Date:  2014-10-02       Impact factor: 5.505

Review 7.  Bypassing the Blood-Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies.

Authors:  Manuela Gernert; Malte Feja
Journal:  Pharmaceutics       Date:  2020-11-24       Impact factor: 6.321

Review 8.  Chronopharmacology of anti-convulsive therapy.

Authors:  Sriram Ramgopal; Sigride Thome-Souza; Tobias Loddenkemper
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 9.  The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine.

Authors:  Detlev Boison
Journal:  Front Mol Neurosci       Date:  2016-04-13       Impact factor: 5.639

10.  Genome Editing in Neuroepithelial Stem Cells to Generate Human Neurons with High Adenosine-Releasing Capacity.

Authors:  Daniel Poppe; Jonas Doerr; Marion Schneider; Ruven Wilkens; Julius A Steinbeck; Julia Ladewig; Allison Tam; David E Paschon; Philip D Gregory; Andreas Reik; Christa E Müller; Philipp Koch; Oliver Brüstle
Journal:  Stem Cells Transl Med       Date:  2018-03-28       Impact factor: 6.940

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.